Matches in SemOpenAlex for { <https://semopenalex.org/work/W1533541750> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W1533541750 abstract "Since the poor outcome for advanced lung cancer with first-line chemotherapy, more efforts should be paid for treatment of advanced recurrent or metastasis non-small cell lung cancer (NSCLC) patients. Pemetrexed, as a multi-target antifolate chemotherapeutic drug, was approved for the second-line treatment of advanced NSCLC. The aim of this study is to evaluate the efficacy and side effects of pemetrexed combined with cisplatin/carboplatin in the treatment of advanced recurrent or metastasis NSCLC.Sixty-three advanced recurrent or metastasis NSCLC patients confirmed with pathology or cytology were enrolled in this study. Among them, 40 cases were male and 23 were female, with 62 years of median age. The combination regimen was patients received pemetrexed 500 mg/m² on day 1 and cisplatin 30 mg/m² on day 1, day 2 and day 3 or carboplatin 300 mg/m² on day 1 by intravenous infusion, with 21 days as one cycle. All patients who received 2 or more cycles could be evaluated.Only 1 case got complete response, with 5 cases partial response, 36 stable and 21 cases progressive. The overall control rate was 66.7% (42/63). The median survival time was 9.0 months, while the median progression-free survival was 5.0 months (3.0 months in squamous cell carcinoma; 5.5 months in adenocarcinoma). There was a significant difference between squamous cell carcinoma and adenocarcinoma (P=0.017). The common adverse effects were leucopenia, anemia and gastrointestinal response.Pemetrexed combined with cisplatin/carboplatin is effective and feasible for advanced recurrent or metastasis NSCLC." @default.
- W1533541750 created "2016-06-24" @default.
- W1533541750 creator A5012700373 @default.
- W1533541750 creator A5017963093 @default.
- W1533541750 creator A5027835055 @default.
- W1533541750 creator A5062810160 @default.
- W1533541750 creator A5085620444 @default.
- W1533541750 creator A5089375313 @default.
- W1533541750 date "2011-01-01" @default.
- W1533541750 modified "2023-09-27" @default.
- W1533541750 title "[Pemetrexed combined with cisplatin or carboplatin regimen in the treatment of advanced recurrent or metastasis non-small cell lung cancer: analysis of 63 cases]." @default.
- W1533541750 doi "https://doi.org/10.3779/j.issn.1009-3419.2011.01.11" @default.
- W1533541750 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5999704" @default.
- W1533541750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21219833" @default.
- W1533541750 hasPublicationYear "2011" @default.
- W1533541750 type Work @default.
- W1533541750 sameAs 1533541750 @default.
- W1533541750 citedByCount "2" @default.
- W1533541750 countsByYear W15335417502012 @default.
- W1533541750 countsByYear W15335417502013 @default.
- W1533541750 crossrefType "journal-article" @default.
- W1533541750 hasAuthorship W1533541750A5012700373 @default.
- W1533541750 hasAuthorship W1533541750A5017963093 @default.
- W1533541750 hasAuthorship W1533541750A5027835055 @default.
- W1533541750 hasAuthorship W1533541750A5062810160 @default.
- W1533541750 hasAuthorship W1533541750A5085620444 @default.
- W1533541750 hasAuthorship W1533541750A5089375313 @default.
- W1533541750 hasConcept C121608353 @default.
- W1533541750 hasConcept C126322002 @default.
- W1533541750 hasConcept C143998085 @default.
- W1533541750 hasConcept C2776256026 @default.
- W1533541750 hasConcept C2776694085 @default.
- W1533541750 hasConcept C2777240266 @default.
- W1533541750 hasConcept C2778239845 @default.
- W1533541750 hasConcept C2778336483 @default.
- W1533541750 hasConcept C2781182431 @default.
- W1533541750 hasConcept C2781413609 @default.
- W1533541750 hasConcept C2781451048 @default.
- W1533541750 hasConcept C71924100 @default.
- W1533541750 hasConcept C90924648 @default.
- W1533541750 hasConceptScore W1533541750C121608353 @default.
- W1533541750 hasConceptScore W1533541750C126322002 @default.
- W1533541750 hasConceptScore W1533541750C143998085 @default.
- W1533541750 hasConceptScore W1533541750C2776256026 @default.
- W1533541750 hasConceptScore W1533541750C2776694085 @default.
- W1533541750 hasConceptScore W1533541750C2777240266 @default.
- W1533541750 hasConceptScore W1533541750C2778239845 @default.
- W1533541750 hasConceptScore W1533541750C2778336483 @default.
- W1533541750 hasConceptScore W1533541750C2781182431 @default.
- W1533541750 hasConceptScore W1533541750C2781413609 @default.
- W1533541750 hasConceptScore W1533541750C2781451048 @default.
- W1533541750 hasConceptScore W1533541750C71924100 @default.
- W1533541750 hasConceptScore W1533541750C90924648 @default.
- W1533541750 hasLocation W15335417501 @default.
- W1533541750 hasLocation W15335417502 @default.
- W1533541750 hasOpenAccess W1533541750 @default.
- W1533541750 hasPrimaryLocation W15335417501 @default.
- W1533541750 hasRelatedWork W1989051367 @default.
- W1533541750 hasRelatedWork W2348406469 @default.
- W1533541750 hasRelatedWork W2358450743 @default.
- W1533541750 hasRelatedWork W2363732038 @default.
- W1533541750 hasRelatedWork W2369760583 @default.
- W1533541750 hasRelatedWork W2378767654 @default.
- W1533541750 hasRelatedWork W2386812582 @default.
- W1533541750 hasRelatedWork W3032772405 @default.
- W1533541750 hasRelatedWork W3111665711 @default.
- W1533541750 hasRelatedWork W4291931441 @default.
- W1533541750 isParatext "false" @default.
- W1533541750 isRetracted "false" @default.
- W1533541750 magId "1533541750" @default.
- W1533541750 workType "article" @default.